Hikma Pharmaceuticals (HKMPY) experienced an 8.8% rise in its stock price during London trading, fueled by rumors of a potential takeover. Although the interested party remains unidentified, past speculation suggests companies like Viatris, Amgen, and Novartis might have considered acquiring Hikma. This development was highlighted by a Betaville "uncooked" alert, sparking investor interest.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.